Clinical Trials · NCT02954458

Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

Name: Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Teduglutide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Shire
Enrollment: 61
Start date: Jan 2017
Locations: 22 sites, 6 countries
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (TEAEs)

View Teduglutide compound reference